𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor vaccines in renal cell carcinoma

✍ Scribed by Hirotsugu Uemura; Marco A. De Velasco

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
370 KB
Volume
26
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor-cell proliferation and prognosis i
Tumor-cell proliferation and prognosis in renal-cell carcinoma
✍ Per Larsson; BΓΆrje Ljungberg; GΓΆran Roos; Roger Stenling πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 551 KB

In the present study the prognostic value of tumor S-phase fraction was evaluated in 69 patients with renal-cell carcinoma. The proportion of S-phase cells was calculated from DNA histograms by flow cytometry in multiple samples from each tumor. The mean tumor S-phase percentage varied between 1.0 a

Recurrent renal cell carcinoma arising i
Recurrent renal cell carcinoma arising in wilms' tumor
✍ William C. Allsbrook Jr.; William C. Boswell Jr.; Hiroyuki Takahashi; Cooley G. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 822 KB

A 19-month-old black girl had a radical nephrectomy for a Wilms' tumor that contained areas of epithelium indistinguishable from renal cell carcinoma. She was treated with chemotherapy but subsequently had pulmonary metastases develop and massive abdominal recurrence. The recurrent tumor was histolo

Antigen loss variants of a murine renal
Antigen loss variants of a murine renal cell carcinoma: Implications for tumor vaccination
✍ Aida Kerkmann-Tucek; G.-AndrΓ© Banat; BjΓΆrn Cochlovius; Margot ZΓΆller πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 307 KB πŸ‘ 1 views

Vaccination with tumour cells genetically modified to support induction of an immune response either by production of cytokines or expression of co-stimulatory molecules provides a promising therapeutic approach. We have evaluated the efficiency of tumour vaccination using RENCA cells, a renal cell